[1]
Mullokulov J.J., Akhmedov Kh.S., «COMPARATIVE EFFICACY AND SAFETY OF BARICITINIB PLUS SULFASALAZINE VERSUS TNF-Α INHIBITORS AND SULFASALAZINE MONOTHERAPY IN REACTIVE ARTHRITIS: A 12-MONTH RANDOMIZED STUDY», ВАПЦА, т. 13, вып. 8, сс. 21–26, окт. 2025, просмотрено: ноя. 19, 2026. доступно на: https://journals.tnmu.uz/index.php/bapca/article/view/2469